Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$706,945
+$139,774 QoQ
Shares Held
35,119
0.0% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#87
of 182 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Derivatives in KALV
reported options exposure · as of Sep 30, 2025CallValue
$4,872,000
CallShares
400,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ikarian Capital, LLC holds $659,799,686 across 106 Biotechnology names. KALV ranks #75 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
1,456,378 | $76,780,248 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,265,795 | $48,252,105 | |
| 3 | ALMS |
Alumis Inc.
|
1,213,548 | $26,734,462 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
428,682 | $24,910,711 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
71,581 | $23,062,682 | |
| 6 | RLMD |
Relmada Therapeutics, Inc.
|
2,688,359 | $18,710,978 | |
| 7 | CYTK |
Cytokinetics Inc
|
283,572 | $18,690,230 | |
| 8 | TENX |
Tenax Therapeutics, Inc.
|
1,017,600 | $16,271,424 |
All Filings in KALV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $706,945 | 35,119 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $567,171 | 35,119 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $4,872,000 | 400,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $4,522,000 | 400,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $2,244,359 | 198,528 | Shares | Sole | 2025-08-14 | |
| 2023-09-30 | $1,374,123 | 142,692 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,260,000 | 140,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,100,400 | 140,000 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $585,620 | 39,730 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $483,900 | 36,576 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,685,251 | 96,576 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,323,281 | 96,965 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $7,629,030 | 296,965 | Shares | Sole | 2021-08-18 | |
| 2020-12-31 | $20,204,619 | 1,063,961 | Shares | Sole | 2021-02-12 | |
| 2020-12-31 | $2,763,045 | 145,500 | Call | Sole | 2021-02-12 | |
| 2020-09-30 | $15,554,579 | 1,235,471 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $13,472,079 | 1,113,395 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,241,528 | 946,605 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||